Sunday November 22 2009 | Biotechnology feed | All feeds

BioTrends Research Group, Inc.

Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Raptiva Withdrawal Offers Upside for Enbrel and Humira According ... Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists. EXTON, Pa., May 28 /PRNewswire/ ...
http://www.drugs.com/news/raptiva-offers-upside-enbrel-humir...
New Safety Regulations Drive Greater Need for Resources and ... Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists. Other News Releases in Surveys, ...
http://www.prnewswire.com/news-releases/new-safety-regulatio...
Drugs.com - Pharma Industry News Archive May 2009 May 28, Raptiva Withdrawal Offers Upside for Enbrel and Humira According to Latest BioTrends Survey of U.S. Dermatologists. May 28, Genentech tops MSImage
...
http://www.drugs.com/news-archive/May-2009.html...
Health News from PR Newswire – Get the latest Health news at PR ... Latest Health news releases distributed by PR Newswire including multimedia press releases, investor relations and disclosure, and company news.
http://www.prnewswire.com/news-releases/health-latest-news/b...

Browse other news from this organisation: BioTrends Research Group, Inc.

(If any, Generated Automatically)

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.